참고문헌
- Health Insurance Review and Assessment Service. 2015 Medical expenses statistical indicators. Wonju: Health Insurance Review and Assessment Service; 2015.
- Lee YT, Kim JE, Kim EY, Park JS, Hwang JW, Jeong SW. Study on the improvement of pricing system for medical devices. Cheongju: Korea Health Industry Development Institute, National Health Insurance Service; 2012.
- Choi YJ, Nam HJ, Chae JM. Research on a reasonable pricing policies for medical devices. Wonju: Health Insurance Review and Assessment Service; 2015.
- Shin CM, Lee SM, Nam MH, Kim YE, Lee JY, Lee YJ, et al. Reasonable management plan for medical devices expenditure in NHI. Seoul: National Evidence-based Healthcare Collaborating Agency, National Health Insurance Service; 2011.
- Timmermans S, Berg M. The practice of medical technology. Sociol Health Illn 2003;25:97-114. DOI: https://doi.org/10.1111/1467-9566.00342.
- Bae EY. Reimbursement and pricing policies for medical devices and health technology assessment. Health Welf Forum 2014;(212):26-35.
- Korea Health Industry Development Institute. KIMES 2016 Policy direction for health insurance [Internet]. Cheongju: Korea Health Industry Development Institute; 2016 [cited 2016 Aug 10]. Available from: https://www.khidi.or.kr/board/view?linkId=177414&menuId=MENU00349.
- The Global Harmonization Task Force. Definition of the terms 'medical device' and 'in vitro diagnostic (IVD) medical device [Internet]. Geneva: World Health Organization; 2012 [cited 2016 Aug 10]. Available from: http://www.who.int/medical_devices/definitions/en/.
- Choi SE, Park HY, Bae SY, Han EA, Bae EM, Ahn HT, et al. A study on policy recommendations for post-monitoring system of the medical devices. Wonju: National Health Insurance Service, Korea University Research & Business Foundation; 2014.
- Health Insurance Review and Assessment Service. 2016 Management directions for medical devices [Internet]. Wonju: Health Insurance Review and Assessment Service; 2016 [cited 2016 Aug 10]. Available from: https://www.khidi.or.kr/fileDownload?titleId=152212&fileId=2&fileDownType=C¶mMenuId=MENU00349.
- Choi YJ, Cho SJ, Nam HJ, Kang YJ. Policy on the price management based on the quantity of medical device. Wonju: Health Insurance Review and Assessment Service; 2013.
- Borgonovi E, Busse R, Kanavos P. Financing medical devices in Europe: current trends and perspectives for research. Eurohealth 2008;14(3):1-3.
- Shuren J, Califf RM. Need for a national evaluation system for health technology. JAMA 2016;316(11):1153-1154. DOI: https://doi.org/10.1001/jama.2016.8708.
- Brown A, Meenan BJ, Young TP. Price trend analysis and its implications for the development of new medical technologies. Conf Proc IEEE Eng Med Biol Soc 2007;2007:5156-5159. DOI: https://doi.org/10.1109/iembs.2007.4353502.
- Brown A, Meenan BJ, Young TP. Marketing innovation: medical device prices follow the experience curve. J Med Mark 2007;7(3):203-212. DOI: https://doi.org/10.1057/palgrave.jmm.5050086.
- Girling AJ, Freeman G, Gordon JP, Poole-Wilson P, Scott DA, Lilford RJ. Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy. Int J Technol Assess Health Care 2007;23(2):269-277. DOI: https://doi.org/10.1017/s0266462307070365.
- Rogalewicz V, Ujhelyiova A, Pousek L, Sinkorova V, Kneppo P. Health technology assessment and medical devices. New York (NY): IEEE; 2011.
- Health Insurance Review and Assessment Service. Therapeutic materials price list(2016.3.1).Wonju: Health Insurance Review and Assessment Service;2016
- Lee EJ. Status and improvement tasks of arbitrary uninsured benefits. Welf Trends 2012;(165):14-17.
- Choi JK. Problem and improvement of health insurance reimbursement system: focusing on arbitrary uninsured benefits. Health Policy Forum 2008;6(4):91-97.
- Choi YJ, Chae JM, Nam HJ, Choi YM. Reimbursement decisions for the evidence-based medical device: economic evaluation guidelines. Wonju: Health Insurance Review and Assessment Service; 2015.
- Jang SM, Pakr CM, Choi YJ, Bae GR. Analysis of determinants of inpatient pharmaceutical expenditure in NHI. Korean J Health Econ Policy 2010;16(3):115-137.
- Park SB, Kim DJ, Park EJ, Lee SK, Kim SW. Study on the rationalization the post-management system of medicines price. Sejong: Korea institute for Health and Social Affairs, National Health Insurance Service; 2015.
- Byeon JO, Kim YR, Lee JH. Population-based health insurance pharmaceutical expenditure and analysis of determinants. Wonju: National Health Insurance Service; 2015.
- Patented Medicine Prices Review Board. The drivers of prescription drug expenditures: a methodological report. Ottawa (ON): Patented Medicine Prices Review Board; 2013.
- Haute Autorite de Sante. Medical device assessment in France guide book [Internet]. Saint-Denis: Haute Autorite de Sante; 2009 [cited 2016 Aug 10]. Available from: http://www.has-sante.fr.
- Private Healthcare Australia. Prostheses list [Internet]. Deakin (ACT): Private Healthcare Australia; 2016 [cited 2016 Aug 10]. Available from: http://www.privatehealthcareaustralia.org.au/for-providers/prostheses-list.
- Malenka DJ, Kaplan AV, Sharp SM, Wennberg JE. Postmarketing surveillance of medical devices using Medicare claims. Health Aff (Millwood) 2005;24(4):928-937. DOI: https://doi.org/10.1377/hlthaff.24.4.928.
- Pammolli F, Riccaboni M, Oglialoro C, Magazzini L, Baio G, Salerno N. Medical devices competitiveness and impact on public health expenditure. Luxembourg: Office for Official Publications of the European Communities; 2005.
- Beckert J. Where do prices come from?: sociological approaches to price formation. Socioecon Rev 2011;9(4):757-786. DOI: https://doi.org/10.1093/ser/mwr012.